Agata Bzymek-Waśniewska and Marta Sroka-Maleta jointly lead the team at DBS Law Firm; the former is noted for her broad expertise in sector-specific labour law issues, and promotional, logistics, and distribution issues within the pharmaceutical industry, while the latter is particularly active on mandates concerning changes to pharmaceutical, reimbursement and IP legislation. The ‘very well seasoned’ group exhibits deep regulatory knowledge of orphan drugs and international drug launches. Andrzej Siwiec was promoted to partner in January 2023, and has extensive regulatory knowledge, advising on a range of market access and business development projects.
Testimonials
Collated independently by Legal 500 research team.
‘The team is very knowledgeable in the specialised life sciences regulations across the EU. Good practical advice without making matters excessively complex.’
‘Andrzej Siwiec is always responsive, addresses queries promptly, has a good understanding of life sciences regulations, provides practical advice.’
Key clients
- Alpen Pharma Polska
- Avanzanite Bioscience
Work highlights
- Advising a global pharmaceutical corporation on a possible change to its business model in Poland.
- Advising a Dutch pharmaceutical company on the preparation of a multi-jurisdictional launch and the commercialisation of a medicinal product for a rare disease.